Research Areas

Biomachines announced the formation of a new division--Applied Proteomics Services--from a collaboration with UMass\'s Proteomic Fractionation Group.

Prime Synthesis Inc. announced a new operating division, called 3-Prime LLC, intented to provide support to customers for oligonucleotide production in the research and development market.

ImmunoGen Inc. announced it grants Biotest AG exclusive rights to use ImmunoGen’s Tumor-Activated Prodrug (TAP) technology with antibodies targeting an undisclosed target to develop novel anticancer therapeutics.

Commonwealth Biotechnologies Inc. has struck a deal with PharmAust Ltd. to form a strategic alliance and client referral agreement under which they will co-market their services to the life sciences industry.

KineMed and Organon announced today that they have signed an agreement to discover new applications for multiple drug candidates.

BioSeek announced a collaboration agreement with GSK under which BioSeek will apply its BioMAP systems for the characterization of compounds from GSK.

Canadian Institute of Advanced Research (CIAR) recently announced the formation of new program that will analyze genetic networks as clues to human disease.

Data management company Unleashed Informatics recently introduced its Unleashed Global Services arm to complement its bioinformatics software and hardware offerings.